Nova Biomedical Press Releases


  • Stat Profile Prime Critical Care System Receives FDA Clearance for Point-of-Care Use

    Posted June 11th, 2015

    Waltham, MA – Nova Biomedical’s new generation blood gas analyzer, Stat Profile Prime, has been cleared by the U.S. Food and Drug Administration (FDA) for point-of-care (POC) use, allowing non-laboratory, POC personnel to perform bedside, critical care testing with lab-quality results.Details


  • Nova StatStrip Xpress Glucose Hospital Meter System Receives FDA Clearance Use with Critically Ill Patients

    Posted May 26th, 2015

    Waltham, MA – On May 20, 2015, the U.S. Food and Drug Administration (FDA) cleared Nova Biomedical’s StatStrip Xpress Glucose Hospital Meter System for use throughout all hospital and all professional healthcare settings, including critically ill patients. Details


  • Nova StatStrip Glucose Hospital Meter System Now Offers Wireless Meter Connectivity Only glucose meter FDA-cleared for use with all patients, including critically ill

    Posted May 7th, 2015

    Waltham, MA – Nova Biomedical’s StatStrip Glucose Hospital Meter System now offers bidirectional wireless connectivity to the hospital’s HIS or LIS with complete security to protect patient data. Details


  • Nova StatStrip Glucose Hospital Meter System Receives FDA Clearance for Intensive Care Use

    Posted September 25th, 2014

    Only glucose monitoring system FDA-cleared for use throughout all hospital settings, all professional healthcare settings, and all patient populations including critical care FOR IMMEDIATE RELEASE: September 25, 2014 Contact: Ron Newby, Director of Marketing Phone: (781) 894-0800 Waltham, MA – Nova Biomedical’s StatStrip Glucose Hospital Meter System is the first blood glucose monitoring… Details


  • Nova Biomedical Simplifies Critical Care Testing with Next Generation Blood Gas Analyzer

    Posted May 12th, 2014

    Waltham, MA – Nova Biomedical simplifies critical care testing with Stat Profile Prime®, a new blood gas analyzer that combines the revolutionary micro-electronics of the consumer world with Nova’s innovative ZERØ™ maintenance cartridge technology for a smaller, faster, and less expensive critical care analyzer. Stat Profile Prime’s ZERØ™ maintenance cartridge technology consists of individual cartridges. Details


  • Nova to Hold Its 25th Annual Scholarship Awards Dinner and Fund Raiser on May 17th, 2014

    Posted February 4th, 2014

    Waltham, MA (February 2nd, 2014) The Nova Scholarships were started in 1989. The Scholarship program includes two distinct scholarship funds: The Thomas Gross Scholarships, established in 1989, and the Frederick Spaziani Scholarship, established in 1992. Since the first Scholarship Awards in 1990, Nova has given a total of $1,899,000 in scholarships and awards. Details


  • Study demonstrates effective cell culture control and real‐time adjustment of metabolites for improved process control in development activities

    Posted September 17th, 2013

    ABSTRACT: Current initiatives within the biopharmaceutical industry to adopt PAT (Process Analytical Technology) approaches in manufacturing, include activities in early process development. With adherent cell lines, online sampling for real‐time process monitoring and process adjustment is challenging due to the viscosity of the cell culture and potential blockages to sampling systems caused by microcarriers. Details


  • BioProfile FLEX Autosampler aids in significant productivity improvement in Genentech study

    Posted September 6th, 2013

    Waltham, MA (February 2nd, 2014) The Nova Scholarships were started in 1989. The Scholarship program includes two distinct scholarship funds: The Thomas Gross Scholarships, established in 1989, and the Frederick Spaziani Scholarship, established in 1992. Since the first Scholarship Awards in 1990, Nova has given a total of $1,899,000 in scholarships and awards. Details


  • New Study Shows Lactate Plus provides accurate and reproducible measurements of blood lactate.

    Posted September 6th, 2013

    Objectives: The aims of this study were to: (1) determine the validity and reliability of the Nova Biomedical Lactate Plus portable analyzer, and quantify any fixed or proportional bias; (2) determine the effect of any bias on the determination of the lactate threshold and (3) determine the effect that blood sampling methods have on validity… Details


  • New Study Demonstrates Nova Max Plus Meter (SMBG) Is Most Accurate Glucose Meter

    Posted February 12th, 2012

    Waltham, MA (September 22, 2011) – Nova Max® Plus proved to be more accurate than other leading brand self-monitoring blood glucose meters (SMBG) in a study presented September 14th, 2011 at the European Association for the Study of Diabetes (EASD). The study was performed by the Clinical Translational Research and Innovation Center, University of Ulster,… Details


  • Strong Growth Prompts Nova Biomedical to Increase Manufacturing Capability With Purchase of 80,000 Square-foot Facility

    Posted February 12th, 2012

    Waltham, MA, January 2011 — Nova Biomedical today announced that, in response to rapid growth in its diabetes and whole blood point-of-care testing products business, it has purchased an additional 80,000 square-foot manufacturing/warehouse facility in Billerica, MA. According to Lou Borrelli, Nova Biomedical CFO, “This additional state of the art manufacturing facility will ensure that… Details


  • U.S. Senator Scott Brown Visits Nova Biomedical

    Posted February 12th, 2012

    On April 28, 2011, United States Senator Scott Brown (R. MA) visited Nova Biomedical, the largest privately held in vitro diagnostic company in the U.S. and one of the largest employers among Massachusetts medical device companies. During his visit, Senator Brown toured Nova’s 300,000 square foot manufacturing, research and development facility in Waltham, Massachusetts, and… Details


  • Wireless Connectivity Now Available for Nova’s Hospital Meters

    Posted February 12th, 2012

    Waltham, MA, March 31, 2011 – Nova Biomedical announces the availability of a wireless connectivity solution for StatStrip® Glucose and StatSensor® Creatinine meters. The Nova StatStrip Wireless Tote provides bi-directional, wireless connectivity of StatStrip or StatSensor test results and patient data to/from a Lab or Hospital Information System (LIS) and is a convenient, lightweight carrying…Details


  • Nova Now Helping Lifescan Users Transition to Nova StatStrip Glucose Meters and Strips

    Posted February 12th, 2012

    On January 14, 2011, LifeScan announced they were withdrawing from the hospital point-of-care glucose testing market in North America. The announcement provided LifeScan users with a brief, 26-month period to identify, evaluate, and implement a new partner. Nova Biomedical is prepared to help you begin now to transition to a new POC glucose partner to… Details


  • Nova’s Diabetes Care Products Held Not To Infringe Roche’s Claims

    Posted February 12th, 2012

    On July 27, 2010 The Honorable Joseph J. Farnan of the United States District Court for the District of Delaware issued an order granting client Nova Biomedical Corporation’s motion for summary judgment of non-infringement of two patents asserted by Roche Diagnostics Operations Inc. and Corange Int’l Ltd. The Court’s order is based on the September… Details


  • Nova Biomedical Awarded Multi-Year Glucose Monitoring System Agreement With Premier, Inc.

    Posted February 12th, 2012

    Waltham, MA. January 2010 – Nova Biomedical announced it has been awarded a new multi-year glucose monitoring system agreement with Premier Purchasing Partners, the group purchasing unit of Premier, Inc. This new agreement provides Premier members access to contracts for Nova’s lab-accurate and interference-free StatStrip® Glucose technology for monitoring glucose levels in hospital patients. The… Details


  • Nova Biomedical’s StatStrip Xpress Glucose Meter Receives FDA CLIA Waived Designation

    Posted February 12th, 2012

    Waltham, MA. – Nova Biomedical’s StatStrip® Xpress™ glucose monitor has been granted CLIA-waived status from the U.S. Food and Drug Administration. StatStrip Xpress is Nova’s non-connectivity companion meter to the CLIA-waived StatStrip Hospital Glucose Meter. StatStrip Xpress can now be operated under a certificate of waiver in point-of-care settings such as ambulances and remote non-hospital locations that do not require the network capabilities of the StatStrip Hospital Glucose Meter.… Details


  • If You Are Not Using Nova’s Glucose StatStrip, You Are Misdosing Dependent Patients Who Have Abnormal Hematocrits

    Posted February 12th, 2012

    If You Are Not Using Nova’s Glucose StatStrip, You Are Misdosing Dependent Patients Who Have Abnormal Hematocrits According to a recent published study1 by the Mayo Clinic, only Nova’s StatStrip continued to give accurate glucose results as patient hematocrits varied from 20% – 65%. Hematocrit related errors of 20% to nearly 50% were reported on… Details


  • Nova Biomedical Corporation Triumphs in High-Stakes Trade Secret Litigation in California

    Posted January 10th, 2012

    Waltham, MA. – December 1, 2009 – Following a three-week trial, a California federal jury on Sept. 11, 2009 awarded a complete victory to Nova Biomedical Corporation against Medtronic MiniMed, Inc., which had brought claims against Nova for misappropriation of trade secrets, breach of contract, tortuous interference and conversion. Medtronic Minimed, a subsidiary of Minneapolis-based…… Details


  • Nova Biomedical and CCS Medical Reach Definitive Agreement for a Subsidiary of Nova Biomedical to Acquire Assets of CCS Medical’s Subsidiary, Sanvita, Inc.

    Posted January 10th, 2012

    Nova Biomedical and CCS Medical Reach Definitive Agreement For A Subsidiary of Nova Biomedical to Acquire Assets of CCS Medical’s Subsidiary, Sanvita, Inc. Waltham, MA. and CLEARWATER, Fla. – September 10, 2009 – Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today Details


  • Automated Modular Analyzer Provides Fast, Comprehensive Cell Culture Analysis

    Posted January 10th, 2012

    A new, automated modular analyzer from Nova Biomedical provides fast, comprehensive analysis for cell culture processing. BioProfile® FLEX provides up to 15 key cell culture attributes, including glucose, lactate, glutamine, glutamate, ammonium, PCO2, PO2, pH, sodium, potassium, calcium, osmolality, cell density/viability, and phosphate in a single, easy to use workstation. This comprehensive test menu provides… Details


  • Nova StatStrip Glucose Analyzer Receives FDA Clearance for Neonatal Testing

    Posted January 10th, 2012

    Nova’s new StatStrip™ Glucose Monitor has received clearance from the U.S. Food and Drug Administration for use in neonatal testing. Severe hematocrit abnormalities are routinely found in neonates. Other glucose monitors may report an error if the hematocrit value is abnormal, StatStrip is the only glucose monitor that measures hematocrit on the strip, automatically correcting…Details


  • First True “No Coding” Blood Glucose Monitoring System Provides Fast, Convenient Solution for Diabetes Self-Testing

    Posted January 10th, 2012

    An advanced blood glucose monitoring system from Nova Biomedical provides a fast, convenient solution for diabetes self-testing. The newly released Nova Max™ system is built around patented* new technology test strips that are so precise they do not require the calibration or coding required of currently available blood glucose monitors to perform a glucose test…. Details


  • “All-in-One” Stat Analyzer Adds Total Bilirubin to Test Menu

    Posted January 10th, 2012

    Nova Biomedical announces the incorporation of total bilirubin (tBil) to the comprehensive test menu on its StatProfile® Critical Care Xpress (CCX) “All-in-One” Analyzers. Bilirubin is an important indicator of liver function. Its intended use is for the adult population, and neonatal patients to be cleared soon. With the addition of total bilirubin, the CCX analyzer…Details


  • Nova Biomedical announces the availability of a new pHOx Ultra blood gas critical care analyzer

    Posted January 3rd, 2012

    Waltham, MA (September 15, 2011) – Nova Biomedical announces the availability of a new blood gas critical care analyzer. pHOx Ultra analyzer offers the most comprehensive features of any whole blood, critical care analyzer. It features the broadest test menu in one analyzer, with 20 user selectable tests including pH, PCO2, PO2, SO2%, Hct, Hb,… Details


  • Point-of-Care Blood Glucose Monitoring System Measures and Corrects Hematocrit and Electrochemical Interferences

    Posted January 10th, 2012

    An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing. The Nova StatStrip™ point-of-care glucose monitor incorporates a patented* new strip technology that uses four measuring wells. Current glucose strips use only one well. Nova’s Multi-Well™ system…Details


  • Novation Contract Awarded to Nova Biomedical

    Posted January 3rd, 2012

    Nova Biomedical is pleased to announce an extension of its contract to provide multi-analyte point-of-care testing instrumentation to Novation through July 31, 2009. Under the terms of the agreement, Nova Biomedical will provide our advanced series of StatProfile® Critical Care Xpress (CCX) analyzers, reagents, and consumables, and our service contracts to Novation members, associates, and… Details


  • StatStrip Glucose and StatSensor Creatinine Meters Now Allow Off-Line Entry of POC Test Results

    Posted January 10th, 2012

    StatStrip® Glucose and StatSensor™ Creatinine Meters Now Allow Off-Line Entry of POC Test Results A new software enhancement for Nova StatStrip® Glucose and StatSensor™ Creatinine point-of-care monitoring systems allows off-line entry of POC test results for immediate data capture. With the enhanced NovaNet™ instrument manager software, operators can use StatStrip touchscreen to manually enter virtually…Details


  • OPC Connectivity Suite Facilitates BioProfile FLEX Bi-Directional Automation and Process Integration

    Posted December 30th, 2011

    A new Connectivity Suite from Nova Biomedical is a complete plug and play solution for use with the BioProfile® FLEX Cell Culture Analyzer that facilitates Nova’s groundbreaking bi-directional automation and product integration. The BioProfile FLEX Connectivity Suite features complete connectivity with all OPC-compliant systems including bioreactor controllers, data historians, overall IT infrastructure, and plant manager…Details


  • Automated High Resolution Cell Density/Viability Analyzer at Moderate Cost

    Posted December 28th, 2011

    BioProfile CDV incorporates advanced, state-of-the-art technology for rapid, accurate measurement of cell density and cell viability in mammalian cell cultures. Based on the widely recognized and accepted trypan blue exclusion method, BioProfile CDV combines advanced technology in robotics, digital imaging and computer algorithms in a highly automated analyzer.Details